Key statistics dashboard for Quantum BioPharma Ltd. (QNTM). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development.
Stock Data
| Price | $3.65 |
| Market Cap | $23M |
| Beta | 0.29 |
| Exchange | NASDAQ |
| Country | CA |
Valuation Multiples
| P/E Ratio | -0.61 |
| Price / Book | 2.90 |
| P/S | 0.00 |
| P/FCF | -4.09 |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Financial Health
| Current Ratio | 1.20 |
| Quick Ratio | 1.19 |
| Cash Ratio | 0.44 |
| Debt / Equity | 0.12 |
| Debt / Assets | 6.69% |
| Interest Coverage | -5.00 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -26.98 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 0.92 |
| Cash per share | 1.46 |
| FCF per share | -0.81 |
| Tangible Book Value per share | 0.27 |
| Dividend per share | 0.00 |
Related companies: ANVS · ATNM · BCAB · CELU · CPIX · EVAX · PYPD
Explore sector: Healthcare · Biotechnology
More sections of QNTM: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks